Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by willibrichon Nov 22, 2010 9:40pm
525 Views
Post# 17742739

BWN shareholders know best

BWN shareholders know bestBWN closed up  to finish the day at .80. Note that BWN opened at .69, with an intraday high of .94 and closed much higher than it's open price.  BWN , with 88.7 million shares added 25.7 million dollars of value today.

By contrast.............QEI  opened at  .22 and actually closed lower than it's opening. ( at .21 )  And with 373.14 million shares , QEI only added 8.07 million dollars of value to it's market capitalization.

Let's face it QEI is still being played by traders with deep pockets and lots of confidence. Because they have done this with dozens of other companies. And the only reason that they are still hanging around is because they were successfull in '' shaking the tree '' and grabbing a few million more shares at .17 to .18.5.

Investors should really spend some time and get to know their company.................get to know the company's industry and not be scared into selling out on the basis some price manipulation of their shares.
Bullboard Posts